CRH PLC/ IE0001827041 /
08/09/2023 17:30:30 | Chg. - | Volume | Bid17:30:30 | Ask17:30:30 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
50.92EUR | - | 1.07 mill. Turnover: 26.52 mill. |
-Bid Size: - | -Ask Size: - | 55.54 bill.EUR | - | - |
GlobeNewswire
14/06
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritini...
GlobeNewswire
14/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
GlobeNewswire
03/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
GlobeNewswire
06/05
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire
28/03
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire
14/03
HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI...
GlobeNewswire
26/02
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
GlobeNewswire
12/02
Martin Marietta Announces Acquisition of Aggregates Operations From Affiliates of Blue Water Industr...
GlobeNewswire
30/01
Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
GlobeNewswire
18/12/2023
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
GlobeNewswire
11/12/2023
Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (lu...
GlobeNewswire
11/12/2023
Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib ...
GlobeNewswire
21/11/2023
Martin Marietta to Divest South Texas Cement and Related Concrete Operations to CRH plc
GlobeNewswire
14/11/2023
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
30/10/2023
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire
27/10/2023
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
GlobeNewswire
23/10/2023
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th